Expanded Access to Everolimus, for an Individual Patient With Uterine Sarcoma (CTMS#18-0020)
Latest Information Update: 02 Jun 2025
At a glance
- Drugs Everolimus (Primary)
- Indications Sarcoma; Uterine cancer
- Focus Expanded access; Therapeutic Use
Most Recent Events
- 28 May 2025 Status changed from recruiting to completed.
- 12 Apr 2018 New trial record